Antimicrobials 2019
 
Antimicrobials 2020
 
 
Next year's 21st Annual Scientific Meeting will be held at the Melbourne Convention Centre from Thursday, 27 February until Saturday, 29 February 2019. 
 

Plenary Speakers
 
Dr Nick Daneman, Sunnybrook Healch Sciences Centre, Canada
Talk: "Optimising Treatment and Preventing HAI"
 
Dr Nick Daneman is a Clinician Scientist and Division Head of infectious diseases at Sunnybrook Health Sciences Centre at the University of TOronto, and is an adjunct scientist at the Institute for Clinical Evaluative Sciences and Public Health Ontario. He has been supported by a Clinician Scientist salary award from the Canadian Institute for Health Research, and is the inaugural chair of the Association of Medical Microbiology and Infectious Diseases Canada Clinical Research Network (AMMI CRN). Using hospital, clinical trial, and population-based data sources, his research program aims to maximise the benefits while minimising the harms of antimicrobial treatment.
 
 
Dr Eric Pamer, Sloan Kettering Institute, USA
Talk: "How Antibiotics Disrupt the GI Tract"
 
Eric Pamer received his MD degree from Case Western Reserve University Medical School and completed clinical training in Internal Medicine and Infectious Diseases at UCSD Medical Center. He was a postdoctoral fellow with Charles E. Davis at UCSD, Maggie So at Scripps Research Institute and Michael Bevan at the University of Washington and then moved to Yale University and established a laboratory focusing on immune responses to microbial infection. In 2000 he moved his laboratory to Memorial Sloan-Kettering Cancer Center in New York where he is Head of the Division of Subspecialty Medicine. Since 2010, Doctor Pamer is also Director of the Center for Microbes, Inflammation and Cancer, which focuses on the role of microbes in the development, progression and treatment of cancer.
 
Doctor Pamer's research focuses on the impact of the intestinal microbiota on resistance to Vancomycin-resistant Enterococcus faecium, Clostridium difficile and Klebsiella pneumoniae infections in patients receiving cancer treatment, with a specific focus on highly immunocompromised patients undergoing allogeneic hematopoietic stem cell transplantation. The Pamer laboratory also investigates the role of inflammatory monocytes in defense against infection and the interaction between intestinal microbes and the mammalian immune system.
 
 
A/Prof Deborah Williamson, The Doherty Institute, Australia
Talk: "AMR Outside the Hospital"
 
Associate Professor Deborah Williamson is Deputy Director of the Microbiological Diagnostic Unit Public Health Laboratory at The Doherty Institute, The University of Melbourne. She holds a PhD from The University of Auckland and is a NHMRC Early Career Fellow and Laboratory Head in the Department of Microbiology and Immunology at The University of Melbourne. Her research focus is on the application of microbial genomics to public health, with a particular focus on antimicrobial-resistant organisms.
 

Howard Florey Oration
 
Dr Lindsay Grayson, Austin Health, Australia
Topic: TBC
 
Bio to follow 
 

Symposium Topics
 
The following topics will be covered during the Meeting symposia: 
  • Surveillance
  • IV Drug Use
  • Critiquing the Guidelines
  • Non-antimicrobial Approaches / Treatments
  • The Importance of Laboratory Detection
  • Multiplex Platforms - More answers than Questions
  • The Year in Review
  • Pharmacy